Cargando…
Impact of BSE on the biotechnology industry — detection and risk assessment
This feature briefly looks at filtration technologies that are being developed by Pall Corp to reduce the potential risk of ‘Mad Cow Disease’ in biological products and drugs. It also provides details of proprietary technology that is designed to reduce prions from blood prior to a transfusion.
Autor principal: | Atkinson, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148827/ http://dx.doi.org/10.1016/S0958-2118(04)00238-1 |
Ejemplares similares
-
The legacy of BSE
Publicado: (2011) -
Conversion of the BASE Prion Strain into the BSE Strain: The Origin of BSE?
por: Capobianco, Raffaella, et al.
Publicado: (2007) -
BSE meeting at CDC.
Publicado: (1996) -
BSE and Human Disease
por: Rossor, M N
Publicado: (1996) -
Preclinical Detection of Variant CJD and BSE Prions in Blood
por: Lacroux, Caroline, et al.
Publicado: (2014)